3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
4
Breast Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Metastatic Solid Tumors
1
Locally Advanced or Metastatic Unresectable Urothelial Cancer
1
Glioblastoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Interventions
Cisplatin
4
Radiotherapy, Intensity-Modulated
3
Cetuximab
3
Radiation
2
Bupropion
2
sodium thiosulfate
1
pembrolizumab
1
durvalumab
1
Varenicline
1
Tobacco Use Cessation Devices
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Pilocarpine
1
Oral Hygiene
1
Nicotine Replacement Therapy
1
Nicotine
1
NVP-BKM120
1
Immunoglobulin G
1
Gene Expression Profiling
1
Fluorodeoxyglucose F18
1
FPP(RGD)2
1
Early Intervention, Educational
1
Drug Therapy
1
Doxepin
1
Disulfides
1
Counseling
1
Celecoxib
1
Acupuncture Therapy
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hypopharyngeal Neoplasms
×
sacituzumab govitecan
×
Clear all
No trials found.